On US stock markets, the indices continued their record series on Friday. In addition to the stronger-than-forecast US labor market report, the prospect of a drug from the pharmaceutical company Pfizer in the fight against the corona pandemic with a high effectiveness (almost 90% protection against a severe course) provided further positive momentum. The Dow Jones Industrial closed +0.56% higher at 36'327.95 points, posting a weekly gain of +1.4%. The S&P 500 gained +0.37% to 4'697.53 points. On the Nasdaq technology exchange, the indices remained virtually unchanged after the strong rally.
In Asia, despite the positive guidance from overseas and better-than-expected export data from China (+27.1% vs. consensus +24.5%), stock markets didn't follow at the start of the week and tended in the majority slightly in negative territory.
This week, the focus of the ongoing corporate reporting season is now on Europe. On Tuesday, pharmaceutical giant Bayer and Covid-19 vaccine developer BioNTech will present their quarterly figures. This will be followed on Wednesday by Allianz, Adidas and, from the US, the entertainment group Walt Disney. On Thursday, Siemens, Merck KGaA and the British luxury goods group Burberry will continue. The week concludes with the results of Richemont, Deutsche Telekom and the pharmaceutical group AstraZeneca.
After months of tough wrangling, the USD 1.2 trillion infrastructure package was passed by congress in Washington. This represents an important political victory for the US President, who is currently under pressure, particularly in domestic politics. US President Joe Biden said “the program would create millions of jobs and pave the way for the US to win the economic competition in the 21st century against China and other large countries.” Biden now wants to sign the bill into law as soon as possible at a formal ceremony. In the meantime, however, the dispute over the second billion-dollar package of legislation to expand social benefits and protect the climate is entering the next round in the House of Representatives.
Employment in the United States surged in October and the unemployment rate fell more sharply than expected. According to the report, 531'000 new jobs were created last month (excluding the agricultural sector). Analysts had expected an average increase of 450'000 jobs. In addition, the Labor Department in Washington revised the figures for the previous two months upward by a total of 235'000 jobs. The unemployment rate fell to 4.6% in October, from 4.8% in September (consensus 4.7%). Although the US labor market is still in the recovery phase from the corona crisis – the unemployment rate was 3.5% in February 2020 – the Federal Reserve is likely to feel vindicated in the monetary policy turnaround it implemented last week, also because wage growth has accelerated noticeably in recent months. In October, average hourly wages rose by +4.9% over the year.
The phase of weakness in the German industry continued in September. Industrial production in Germany fell by -1.1% month-on-month, whereas analysts had expected a recovery. Against the background of continuing supply bottlenecks for raw materials and intermediates, the decline in German industry seen since April thus continued. In France, the second largest economy in the eurozone, industrial production also fell by -1.3% in September.
|07:45||SZ||Unemployment Rate (October)||2.8%|
|10:30||EZ||Sentix Economic indicator (November)||+16.9|
Publisher: LGT Bank (Switzerland) Ltd., Glärnischstrasse 36, CH-8027 Zurich
Editor: Alessandro Fezzi, +41 44 250 78 59, E-Mail: email@example.com
Source: LGT Bank (Switzerland) Ltd.
Risk Disclosure (Disclaimer)
This publication is an advertising material / marketing communication. This publication is for your information only and is not intended as an offer, solicitation of an offer, or public advertisement to buy or sell any investment or other specific product. Its content has been prepared by our staff and is based on sources of information we consider to be reliable. However, we cannot provide any confirmation or guarantee as to its being correct, complete and up to date. The circumstances and principles to which the information contained in this publication relates may change at any time. Information that has been published should therefore not be understood as implying that no change has taken place since its publication or that it is still up to date. The information in this publication does not constitute an aid for decision-making in relation to financial, legal, tax-related or other consulting matters, nor should any investment decisions or other decisions be made on the basis of this information alone. It is recommended that advice be obtained from a qualified expert. Investors should be aware that the value of investments can fall as well as rise. Positive performance in the past is therefore no guarantee of positive performance in the future. Investments in foreign currencies are also subject to fluctuations in exchange rates. We disclaim all liability for any loss or damage of any kind, whether direct, indirect or consequential, which may be incurred through the use of this publication. This publication is not intended for persons subject to legislation that prohibits its distribution or makes its distribution contingent upon an approval. Any person coming into possession of this publication shall therefore be obliged to find out about any restrictions that may apply and to comply with them. In line with internal guidelines, persons responsible for compiling this report are free to buy hold and sell the securities referred to in this report.